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Control of ovarian primordial follicle activation
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The ovarian follicles develop initially from primordial follicles. The majority of ovarian primordial follicles are maintained quiescently as a reserve 
for the reproductive life span. Only a few of them are activated and develop to an advanced follicular stage. The maintenance of dormancy and 
activation of primordial follicles are controlled by coordinated actions of a suppressor/activator with close communications with somatic cells 
and intra-oocyte signaling pathways. Many growth factors and signaling pathways have been identified and the transforming growth factor-
beta superfamily plays important roles in early folliculogenesis. However, the mechanism of maintaining the dormancy and survival of primor-
dial follicles has remained unknown for decades. Recently, since the first finding that all primordial follicles are activated prematurely in mice 
deficient forkhead box O3a, phosphatidylinositol 3 kinase/phosphatase and tensin homolog (PTEN) signaling pathway was reported to be im-
portant in the regulation of dormancy and initial follicular activation. With these informations on early folliculogenesis, clinical application can 
be expected such as in vitro maturation of immature oocytes or in vitro activation of follicles by PTEN inhibitor in cryopreserved ovarian cortical 
tissues for fertility preservation.
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Introduction
The mammalian ovary contains follicles at various developmental 
stages and its function includes the cyclic recruitment, development 
and regression of the follicles. The pool of primordial follicles is main-
tained in dormancy and serves as a reserve for cyclic recruitment of 
follicles and oocytes.
The primordial follicles are maintained in dormancy or activated to 
grow into antral follicles. Some of the antral follicles reach ovulation 
under proper gonadotropin stimulation, however, most of the folli-
cles undergo atresia during follicular development or directly from 
the dormant state [1]. The maintenance of the quiescence and sur-
vival of primordial follicles is important as a reserve to provide oo-
cytes throughout the reproductive life. The mechanisms of the main-
tenance of such a long dormancy of the primordial follicles have re-
mained unknown, however the gonadotropin-dependent process of 
follicular development is otherwise well elucidated [2]. In the control 
of primordial follicle activation, bidirectional communication between 
the oocytes and surrounding somatic cells is involved. The oocytes 
are supported by granulosa cells and oocytes also play an active role 
in the growth of the granulosa cells [3]. 
Recently, it was reported that phosphatidylinositol 3 kinase (PI3K) 
pathway is important for the control of follicular activation. In mouse 
ovaries deficient in forkhead box O3 (Foxo3a), the entire pool of pri-
mordial follicles is prematurely activated [4]. Moreover, with the find-
ings from a transgenic mouse model, it has been shown that the 
PI3K/phosphatase and tensin homolog (PTEN) signaling pathway in-
volves the regulation of dormancy and activation of primordial folli-
cles [5,6]. 
Maintaining the dormancy of primordial 
follicles
The pool of primordial follicles is under inhibitory control, therefore, 
when these inhibitory factors decrease or stimulatory factors increase, 
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the follicles are activated [7]. The activated primordial follicles devel-
op into primary, secondary, and antral follicles, however, most of the 
antral follicles undergo atresia. Only a few of them grow to the pre-
ovulatory stage under the stimulation of gonadotropin [1]. Activa-
tion of the primordial follicles of bovine cortical tissue was noted in 
an in vitro culture in serum-free medium. This implies that the pri-
mordial follicles are under inhibitory control to maintain the dormant 
state [8]. Primordial follicles activate spontaneously in vitro and incu-
bation with exogenous cytokine and growth factors increases the 
number of activated follicles.
Regulation of activation by multiple activator 
and repressor pathways
Multiple activator and repressor or signaling pathways are involved 
in the control of primordial follicle activation. Neurotropin, nerve 
growth factor (NGF) and its tyrosine receptor kinase NTRK1 are im-
portant in follicular activation [9]. Other neurotrophins, such as neu-
rotrophin 4 (NT4), brain-derived neurotrophic factor (BDNF) and their 
receptor NTRK2 are also involved in regulating oocyte survival [10]. 
Some ligands play multiple roles in folliculogenesis. transforming 
growth factor-beta (TGF-β) ligand, growth differentiation factor 9 
(GDF9), and bone morphogenic protein 15 (BMP15) play roles in pre-
antral follicular development in addition to their facilitation of primor-
dial follicle activation. 
1. GDF 9
Treatment of immature rats with recombinant GDF9 leads to an in-
creased rate of follicular activation. The addition of recombinant GDF9 
to human ovarian cortical tissue in vitro increases the activation and 
improves the survival of follicles [11]. In GDF9 null mice, the follicles 
do not progress beyond the first stage and granulosa cell prolifera-
tion is limited [12]. However, oocyte growth is accelerated. These re-
sults suggest that GDF9 plays a role in recruiting granulosa cell while 
limiting the growth of the oocytes. 
2. SMADS
SMADS are downstream intracellular signaling molecules of the 
TGF-β ligands (BMP 4 and 7). SMADS null mice have impaired follicu-
logenesis showing increased numbers of primordial follicles and de-
creased numbers of developed follicles in adult life [13]. 
3. FOXL2
Forkhead boxL2 (Foxl2) is expressed in mammalian eyelids and ova-
ries. In mice, Foxl2 is expressed in pre-granulosa cells and the expres-
sion decreases in the granulosa cells of pre-antral follicles. In humans, 
mutation of the FOXL2 gene causes blepharophimosis-ptosis-epican-
thus-inversus (BPES), an autosomal dominant genetic disease show-
ing eyelid dysplasia and high risk of POF [14]. In Foxl2 inactivated mice, 
though the primordial follicles form normally, they do not develop 
into secondary follicles because pre-granulosa cells do not complete 
the cuboidal transition. Most of the oocytes in primordial follicles are 
activated prematurely, and undergo atresia, which implies the deple-
tion of the primordial follicle pool [15]. FOXL2 in pregranulosa cells 
plays an important role in the quiescence of primordial follicles by in-
hibiting the initiation of the growth of oocytes. 
4. Sohlh1
Spermatogenesis- and oogenesis-specific basic helix-loop-helix-
containing protein 1 (Sohlh1) is expressed in the germ cell clusters 
and in new primordial follicles. Sohlh1 null mice show a rapid de-
crease in the number of oocytes by 7 weeks of age and a defect in 
the primordial to primary transition [16]. 
5. AMH 
AMH and its receptor AMHRII are expressed in granulosa cells. The 
role of AMH in primordial follicle was investigated an Amh
-/- mice. 
Amh deficient mice showed premature depletion of primordial folli-
cles, indicating that AMH inhibits the growth of primordial follicles 
[17]. In mouse ovaries cultured with AMH, growing follicle numbers 
decreased by 40-50% [18], and human ovarian tissue cultured with 
recombinant rat AMH showed decreased growth of primordial folli-
cles [19]. Therefore, AMH plays a role in maintaining quiescence by 
inhibiting the transition from primordial to primary follicles.
Intracellular signaling in oocytes for maintenance 
of dormancy of primordial follicles
1. PTEN 
Phosphatase and tensin homolog deleted on chromosome 10 is a 
negative regulator of PI3K. In the absence of PTEN, phosphatidylino-
sitol 3,4,5-triphosphate (PIP3) increase leads to protein kinase B (Akt) 
signaling. The role of PTEN in primordial follicles was elucidated by a 
study using oocyte-specific Pten deleted mice (OoPten
-/- mice) [6].
Oocyte-specific Pten was deleted from oocytes of primordial folli-
cles in mice by crossing Pten
loxP/loxPmice with transgenic mice express-
ing Gdf-9 promoter-mediated Cre recombinase (Gcre mice) [20]. In 
the OoPten
-/- mice, the primordial follicles are overactivated and grow 
to primary and secondary follicles, which results in the early deple-
tion of the primordial follicle pool. Another study with pten-deleted 
primary oocytes in oocyte- specific Gcre transgenic mice showed 
similar results of follicular overactivation and early depletion [21]. 
These results suggest that PTEN is essential for the maintenance of 
dormancy of primordial follicles [22] (Figure 1).   http://dx.doi.org/10.5653/cerm.2012.39.1.10
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2. TSC (tuberin/tuberous sclerosis complex)
Mammalian target of rapamycin (mTOR) complex 1 (mTORC1) is 
negatively controlled by a heterodimeric complex consisting of two 
molecules: Tsc1 (hamartin) and Tsc2 (tuberin).
TSC1 and TSC2 are products of TSC1 and TSC2 genes, respectively. 
The TSC1 and TSC2 gene mutations occur in autosomal dominant tu-
mor syndrome, tuberous sclerosis [23]. Tsc 1 is considered to be im-
portant for maintenance of the dormancy of primordial follicles. In 
mice with Tsc1 deleted in oocytes (OoTsc1
-/- mice), primordial follicles 
were prematurely activated, which also occurs in OoTsc2
-/- mice [24]. 
These results imply that Tsc1/Tsc2 complex plays a role in regulating 
the quiescence and activation of follicles. In Tsc1 or Tsc2 deletion, 
mTORC1 increases and activates S6K1- rpS6 signaling (p70 S6 kinase-
ribosomal protein), which promotes protein translation and ribo-
some synthesis (Figure 1) [21]. The phenotypes of overactivation of 
primordial follicles in OoTsc1
-/- mice and OoPten
-/- mice are similar. Al-
though both Tsc and PTEN regulate follicular activation by inhibiting 
S6K1-rpS6, Tsc inhibits phosphorylation of S6K1 at threonine 389, 
and PTEN inhibits the phosphorylation at threonine 229 [21]. There-
fore, for the maintenance of the dormancy of primordial follicles, S6K1 
should be suppressed by Tsc and PTEN, respectively.
3. Foxo3a 
Foxo3a is expressed in the nucleus of oocytes of primordial follicles, 
and its expression decreases in primary or growing follicles. The de-
crease of Foxo3a initiates the activation of follicles and growth of oo-
cytes. In Foxo3a-deleted mice (Foxo3a
-/-), follicles are depleted, which 
results in infertility, indicating that Foxo3a is important for maintain-
ing the quiescence of primordial follicles [4]. Foxo3a
-/- mice show a 
phenotype similar to that of Pten
-/- mice. In the Pten deleted mice, 
constant Akt activation causes the suppression of Foxo3a. 
Therefore, both PTEN and Foxo3a play important roles in maintain-
ing the dormancy of primordial follicles and PTEN acts upstream of 
Foxo3a [6]. Akt inactivates Foxo3a through an extracellular signaling 
pathway such as insulin signaling, so the effect of insulin for follicular 
activation is by the inhibition of FOXO3 [25,26].
The signals that maintain the survival and 
activation of primordial follicles
1. PI3K signaling 
PI3K activation is maintained by extracellular signals, and it main-
tains the survival of primordial follicles [27]. The survival of primordial 
follicles is maintained through the PI3K pathway [28]. The communi-
cations between oocytes and the surrounding granulosa cells depend 
on their interactive signaling, and the main ligand-receptor is the re-
ceptor protein tyrosine kinase (RPTK) Kit and its ligand, Kit ligand (KL) 
[29]. Kit exists on the surface of oocytes, and KL is produced in the 
granulosa cells. In early stage oocytes and follicles in which FSH re-
ceptors are not expressed yet, follicular growth is dependent on Kit-
KL signaling [30-32].
PI3K signaling is one of the important pathways activated by Kit-KL 
[33]. KL activates the PI3K pathway in primary oocytes, followed by 
phosphorylation of Akt (protein kinase B) and Foxo3a. In mammals, 
the PI3K pathway is activated by insulin and growth factors and it 
regulates cell proliferation and survival [33]. PI3K phosphorylates 
phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinosi-
tol-3,4,5-triphosphate (PIP3), and PIP3 acts as a secondary messen-
ger and provides the docking sites for 3-phosphoinositide depen-
dent kinase-1 (PDK1) and Akt. Akt enhances cell survival, growth, and 
oocyte activation. Otherwise, PTEN inhibits PI3K by converting PIP3 
to PIP2. The FOXO family is a main target of Akt and it suppresses the 
activation of primordial follicles and maintains dormancy by promot-
ing pro-apoptotic genes (Figure 1) [27]. PI3K signaling is mediated by 
PDK1, and PDK1 activates Akt signaling. PDK1 phosphorylates Akt at 
its threonine residue308, and also phosphorylates S6K1, the kinase 
of rpS6 [34]. In mice with an oocyte-specific Pdk1 deletion, most of 
Figure 1. Illustration of the PI3K pathway signaling pathway. Mole-
cules that maintain the dormancy of the primordial follicles are PTEN, 
Foxo3a, p27, and TSC1/TSC2. Molecules that maintain the survival of 
primordial follicles include PI3K, PDK1, mTORC1, S6K1, and rpS6. RPTK, 
receptor protein tyrosine kinase; PTEN, phosphatase and tensin ho-
molog; PIP2, phosphatidylinositol (4,5)-bisphosphate; PIP3, phos-
phatidylinositol (3,4,5)- triphosphate; PI3K, phosphatidylinositol 3-ki-
nase; PDK1, 3-phospho inositide-dependent protein kinase-1; Akt, 
protein kinase B; FOXO3a, forkhead box O3a; mTORC1,C2, mammali-
an target of rapamycin complex 1,2; TSC1/2, tuberin/tuberous sclero-
sis complex 1,2; S6K1, p70 ribosomal protein S6 kinase 1; rpS6, S6K1-
riboso mal protein S6; p27, cyclin-dependent kinase inhibitor p27
Kip1 
(Modified from Reddy et al. [22]).
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the primordial follicles are depleted directly from the dormant state 
and cause premature ovarian failure. Therefore, it is suggested that 
the suppression of PDK1-Akt-S6K1-rpS6 signaling leads to the deple-
tion of primordial follicles [35]. In double knock-out mice with dele-
tion of both Pten and Pdk1, the premature activation does not occur, 
suggesting that the premature activation of follicles in Pten deletion 
is mediated by PDK1 [36]. PI3K-PDK1 signaling plays an important 
role in the survival and activation of primordial follicles. 
2. mTOR 
Mammalian target of rapamycin (mTOR) is a serine/threonine ki-
nase, and regulates protein synthesis and cell growth. mTOR exists in 
the two forms of mTORC1 and mTORC2. S6K1 is the main substrate 
of mTORC1 and is phosphorylated by mTORC1 [37]. In Tsc1-deleted 
(OoTsc1
-/-) mice treated with mTORC1 inhibitor, the overactivation of 
primordial follicles is suppressed, which implies that mTORC1 is in-
volved in the activation of primordial follicles. These results suggest 
that the mTORC1-S6K1-rpS6 cascade is also important in the survival 
of primordial follicles [21]. mTOR deletion is expected to accelerate 
the loss of primordial follicles [21]. 
In vitro activation of ovarian follicles
In a mouse model, Pten deletion in granulosa cells reduced apopto-
sis and increased cellular proliferation but not tumors [38]. These re-
sults suggest that PTEN inhibitor can activate the primordial follicles. 
Recently, Li et al. [39] reported that short-term treatment of mouse 
ovaries with PTEN inhibitor and PI3K-activating peptide increased 
the activation of primordial follicles with increased nuclear extrusion 
of Foxo3. The size of the ovarian tissue and the number of follicles in-
creased in PTEN inhibitor-treated ovaries. In addition, in the human 
ovarian cortical tissues cultured with PTEN inhibitor and PI3K activa-
tor, primordial follicles developed to the preovulatory stage, after xe-
no-transplantation. Thus follicular activation with PTEN inhibitor can 
be applied to generate more germ cells from cyro-preserved ovarian 
tissue for fertility preservation in cancer patients.
 
Conclusion
Primordial follicle activation is regulated by close interactive com-
munication with somatic cells and oocytes. The dormancy of primor-
dial follicles is maintained by multiple factors such as PTEN, Tsc, Foxo3a, 
Foxl2, and AMH. With the deletion of these factors, follicles are acti-
vated prematurely leading to early depletion of the primordial folli-
cles. To maintain the survival and activation, PI3K signaling mediated 
by PDK1 and mTORC1-S6K1-rpS6 are involved. With this knowledge 
on the regulatory mechanism for dormancy, survival, and activation 
of primordial follicles, possible clinical applications could include in 
vitro maturation of immature oocytes or in vitro activation of follicles 
by PTEN inhibitor in cryopreserved ovarian cortical tissues for fertility 
preservation in cancer patients or diminished ovarian reserve. 
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